| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 961,735 | 1,496,289 | 1,575,249 | | Cost of Revenue | 227,351 | 596,517 | 580,739 | | | Gross Profit | 734,384 | 899,772 | 994,510 | | | Operating Expenses | | Research Development | 91,508 | 160,186 | 129,343 | | Selling General and Administrative | 373,478 | 552,762 | 634,351 | | Non Recurring | 188,551 | 292,261 | 12,229 | | Others | 10,069 | 116,064 | 122,767 | | | | Total Operating Expenses | 663,606 | 1,121,273 | 898,690 | | | | Operating Income or Loss | 70,778 | (221,501) | 95,820 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52,473 | 93,759 | 51,578 | | Earnings Before Interest And Taxes | 123,251 | (127,742) | 144,523 | | Interest Expense |
-
|
-
| 7,838 | | Income Before Tax | 123,251 | (127,742) | 136,685 | | Income Tax Expense | 42,800 | 11,080 | (241,285) | | Minority Interest | 16,009 | (3,840) | (2,875) | | | | Net Income From Continuing Ops | 92,592 | (144,680) | 377,970 | | | Non-recurring Events | | Discontinued Operations | (467,284) | 5,178 | 1,045 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (374,692) | (139,502) | 379,015 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($374,692) | ($139,502) | $379,015 |
|
0.16% Nasdaq 
Income Statement
